SMO Clinplus: Legal Opinion of Beijing Guofeng (Shanghai) Law Firm on the 2023 Annual General Meeting of Shareholders of Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.